Search the Newsreel

QuidelOrtho (QDEL) Stock Sees Fair Value Cut As Analysts Rework Growth Expectations

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. The sharp reset in QuidelOrtho's fair value estimate from US$20.50 to US$12.00 per share sits alongside analyst price targets that now cluster around the US$12 …

Neuberger Berman Group LLC Trims QuidelOrtho Corp (QDEL) Stake -- Shares Trade 59% Below GF Value

Neuberger Berman Group LLC reduced its stake in QuidelOrtho Corp (QDEL) by 4.34% on July 31, 2026, selling shares at $16.77 each. This divestment comes as QuidelOrtho faces significant financial and operational challenges, including a low GF-Score of 45/100 and negative growth trends, despite …

Why QuidelOrtho (QDEL) Stock Is Nosediving

Why QuidelOrtho (QDEL) Stock Is Nosediving What Happened? Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 21.3% in the afternoon session after the company slashed its full-year revenue and earnings forecast, overshadowing a second-quarter earnings beat. For the second quarter, QuidelOrtho reported revenue of …

QuidelOrtho partially recovers from earnings slide, rising 12% (QDEL:NASDAQ)

QuidelOrtho (QDEL) shares rebounded by nearly 12% after a two-session decline triggered by its Q2 earnings release. The company had initially fallen despite beating top and bottom-line estimates due to significant cuts in full-year revenue and EPS guidance and the withdrawal of free cash …

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho (QDEL) reported second-quarter 2026 adjusted earnings and revenues that surpassed analyst estimates. Despite this beat, the company lowered its full-year 2026 guidance due to persistent weakness in the China market and a more conservative outlook for the upcoming respiratory season, leading to a …

QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging

US-based investment company McIntyre Partnerships delivered flat performance in H1 2026, returning 0% gross and -1% net compared to the Russell 2000 Value Index's 23% return. A copy of the letter can be downloaded here. The second quarter results were a complete reversal of …

QDEL Q2 Deep Dive: Guidance Reset Amid China Headwinds and Respiratory Uncertainty

QDEL Q2 Deep Dive: Guidance Reset Amid China Headwinds and Respiratory Uncertainty Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 2.8% year on year to $630.9 million. On the other hand, the company's full-year …

QuidelOrtho (QDEL) Stock Sinks As Cash Burn And Debt Eclipse Progress

QuidelOrtho (NASDAQ:QDEL) Shares Gap Down - Time to Sell?

QuidelOrtho (NASDAQ:QDEL) shares gapped down significantly, opening at $12.67 after closing at $16.32, and later trading near $11.98. The company reported better-than-expected quarterly earnings, with $0.13 EPS against a forecasted loss of $0.05 and revenue of $630.9 million. Despite this, analysts maintain a cautious …

QuidelOrtho stock drops after Q2 results (QDEL:NASDAQ)

QuidelOrtho Corporation (QDEL) stock dropped over 25% following its Q2 2026 earnings report, despite reporting better-than-expected financials. The decline was attributed to the company lowering its full-year outlook, citing significant market headwinds, especially in China. QuidelOrtho's quarterly revenue reached $630.9M, showing approximately 3% year-over-year …

QuidelOrtho Corp Quarterly Earnings Report

QuidelOrtho Corp (QDEL) has released its unaudited quarterly report for the period ended June 28, 2026, detailing a completed acquisition of LEX Diagnostics for $174.6 million, increased borrowings of $2,891.1 million, and a new equity award of 356,555 restricted stock units to its new …

QuidelOrtho (Nasdaq: QDEL) trims 2026 revenue and EPS guidance

QuidelOrtho (Nasdaq: QDEL) has reported its second-quarter 2026 results, showing a 2.8% year-over-year revenue increase to $630.9 million but a GAAP net loss of $92.9 million. The company has trimmed its full-year 2026 financial guidance, reducing expected revenue, adjusted EBITDA, and adjusted EPS, and …

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q2 Revenue $630.9M, vs. FactSet Est of $618.7M

QuidelOrtho Corporation (QDEL) reported its Q2 revenue at $630.9 million, surpassing FactSet's estimate of $618.7 million. This announcement indicates stronger-than-expected financial performance for the company in the second quarter. The article also mentions recent changes in the company's indices and the appointment of a …

All eyes on Quidel earnings as estimates tumble, asset sale looms

Quidel Corporation is set to report its second-quarter earnings after market close on Thursday, August 6, 2026, with analysts anticipating a loss of 4 cents per share. Investor confidence has waned due to declining EPS estimates and uncertainty surrounding the potential $1.5 billion sale …

Quidelortho Corp (QDEL) News, Articles, Events & Latest Updates

This article provides recent news and updates for QuidelOrtho Corp (QDEL), highlighting its strong Q2 2026 earnings and revenue performance, which surpassed analyst estimates. It also includes details about the company's financial results, upcoming earnings reports, and an article discussing the changing landscape of …

Implied Volatility Surging for QuidelOrtho Stock Options

Investors in QuidelOrtho Corporation QDEL need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 18, 2026 $30.00 Put had some of the highest implied volatility of all equity options today. What is …

QuidelOrtho (NASDAQ:QDEL) Shares Down 5.7% - What's Next?

QuidelOrtho (NASDAQ:QDEL) shares dropped 5.7% after the company missed quarterly earnings expectations, reporting a $0.04 loss per share against an anticipated $0.37 profit and a 10.5% year-over-year revenue decline. Analysts maintain a cautious stance with a "Reduce" consensus rating and an average price target …

Earnings Preview: QuidelOrtho to Report Financial Results Post-market on August 06

This article announces that QuidelOrtho (QDEL) is scheduled to release its financial results on August 6, 2026, after the market closes. The company will also host a conference call and webcast on the same day to discuss the results. The release includes information on …

QuidelOrtho (QDEL) Stock Trades Cheap On Sales But Weak On Cash Flow

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. QuidelOrtho stock has seen a steep share price decline over the past few years, yet the current valuation checks still lean toward the shares …

QuidelOrtho Corporation Revenue Breakdown – NASDAQ:QDEL

QuidelOrtho Corporation (NASDAQ: QDEL) generated a total revenue of $2.73 billion USD last year. The "Labs" segment was the top-performing segment, contributing $1.51 billion USD. Geographically, the United States was the largest contributor to revenue, accounting for $1.44 billion USD.

QuidelOrtho Results Will Arrive After Market Close Aug. 6

QuidelOrtho (Nasdaq: QDEL) announced it will report its Q2 2026 financial results after market close on Thursday, August 6, 2026. A conference call will follow at 2:00 p.m. PT / 5:00 p.m. ET to discuss the results, which will be accessible via the "Events …

QuidelOrtho Corporation Actuals & Estimates (NASDAQ:QDEL)

This article provides an in-depth financial overview of QuidelOrtho Corporation (NASDAQ:QDEL), including its current stock price, historical performance, and analyst forecasts. It details the company's financials such as earnings, revenue, net income, and market capitalization, along with upcoming earnings release dates. The article also …

3 Reasons to Sell QDEL and 1 Stock to Buy Instead

3 Reasons to Sell QDEL and 1 Stock to Buy Instead What a brutal six months it's been for QuidelOrtho. The stock has dropped 40.6% and now trades at $16.68, rattling many shareholders. This was partly driven by its softer quarterly results and may …

QuidelOrtho Corp (QDEL) Shares Fall 4.5% -- What GF Score of 43 Tells Investors

QuidelOrtho Corp (QDEL) saw its shares fall 4.5% to $16.58. GuruFocus analysis indicates the stock is undervalued by 55.6% according to its GF Value of $37.36, but it carries a "Possible Value Trap" warning due to its low GF Score of 43/100, weak financial …

QuidelOrtho (QDEL) 7th Annual Evercore ISI HealthCONx Conference Summary

QuidelOrtho (QDEL) discussed its business performance, segment trends, product dynamics, and financial outlook at the 7th Annual Evercore ISI HealthCONx Conference. The company detailed growth in its Labs and Immunohematology businesses, the winding down of U.S. Donor Screening, and stabilizing respiratory revenue. QuidelOrtho also …

QuidelOrtho Corp (QDEL) awards 356,555 restricted stock units to CFO

QuidelOrtho Corp (QDEL) has granted its Chief Financial Officer, Micah W. Young, 356,555 restricted stock units (RSUs). These RSUs will vest in three tranches on July 15, 2027, July 15, 2028, and July 15, 2029, with each unit representing one share of common stock. …

QuidelOrtho CFO Micah Young Receives 356,555 Stock Units

QuidelOrtho (Nasdaq: QDEL) announced that its Compensation Committee approved an inducement grant of 356,555 restricted stock units (RSUs) to Chief Financial Officer Micah Young. The RSUs, granted under the 2026 Inducement Plan per Nasdaq Listing Rule 5635(c)(4) with a grant date of July 15, …